Owner Sanofi-Aventis Deutschland GmbH

Inventors Bender, Norbert; Yusuf, Salim; Schoelkens, Bernward; Rangoonwala, Badrudin

Agent Watermark

Pub. Number AU-B-2009200746

Parent 2005209687

Filing date 25 February 2009

Wipo publication date 19 March 2009

Acceptance publication date 28 July 2011

A61K 31/00 (2006.01)

A61K 31/216 (2006.01)

A61K 31/355 (2006.01)

A61K 31/401 (2006.01) - Proline

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4166 (2006.01)

A61K 31/4174 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 31/612 (2006.01)

A61K 31/616 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system